The overall objectives of this Program Project Application are to test a relatively novel hypothesis of the etiology/pathogenesis of brain cell loss in aging and Alzheimer's Disease (AD). This hypothesis is: """"""""Aging-related changes in mechanisms that regulate calcium homeostasis, both in serum and in the brain, increase susceptibility to neurotoxic influences, and are a primary etiologic factor in the acceleration of neurodegeneration that results in AD"""""""". Elevated intracellular calcium is well-established to be neurotoxic. If this hypothesis is found to be even partly correct, it will suggest new feasible and rational therapeutic approaches that could well have rapid impact on the treatment of AD and, therefore, could exert a major effect on human health and society. The Program Project (PP) consists of five projects and three cores which will test several subhypotheses of the initial causes of calcium dysregulation, including aging-related alterations in calcium regulating hormones (which have specific target sites in brain cells), in free-radical oxidation, in beta-amyloid accumulation, or in cerebral energy metabolism. There is indirect support for a role of each of these processes in neurotoxicity and glucocorticoid hormones have been found to facilitate brain cell loss in aging. The projects will test the effects of these putative causal factors on several models of aging and neuronal degeneration, including aged rats and brain cell cultures. In addition, however, correlational tests of these hypotheses will be conducted directly on autopsy brain tissues from AD subjects, as well as on calcium regulation in living AD subjects. These subjects and materials will be obtained from the UK Alzheimer's Disease Research Center at substantial cost savings. The PP investigators bring together a natural interest in the central theme, as well as multidisciplinary skills in advanced cellular techniques (ion channel recordings, molecular biology, biochemistry, imaging, etc.) and human studies (AD testing, calcium regulation, magnetic resonance imaging, etc.) and thus will provide a strongly integrated, multiple-level focus on the central hypothesis that would not be possible in a series of unrelated projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010836-02
Application #
3091380
Study Section
Neuroscience, Behavior and Sociology of Aging Review Committee (NBSA)
Project Start
1992-08-20
Project End
1997-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74
Chen, Chun-Hau; Li, Wenzong; Sultana, Rukhsana et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76:13-23
Latimer, Caitlin S; Brewer, Lawrence D; Searcy, James L et al. (2014) Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A 111:E4359-66
Butterfield, D Allan; Di Domenico, Fabio; Barone, Eugenio (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta 1842:1693-706
Perluigi, Marzia; Di Domenico, Fabio; Buttterfield, D Allan (2014) Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics. Proteomics Clin Appl 8:73-85
Farr, Susan A; Ripley, Jessica L; Sultana, Rukhsana et al. (2014) Antisense oligonucleotide against GSK-3? in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med 67:387-95
Barone, Eugenio; Di Domenico, Fabio; Butterfield, D Allan (2014) Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. Biochem Pharmacol 88:605-16
Cenini, Giovanna; Fiorini, Ada; Sultana, Rukhsana et al. (2014) An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach. Free Radic Biol Med 76:89-95
Barone, Eugenio; Di Domenico, Fabio; Mancuso, Cesare et al. (2014) The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Neurobiol Dis 62:144-59
Förster, Sarah; Welleford, Andrew S; Triplett, Judy C et al. (2014) Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain. Biochim Biophys Acta 1842:1333-9

Showing the most recent 10 out of 356 publications